Studies in the Development of a Xenograft-Derived Bone

Total Page:16

File Type:pdf, Size:1020Kb

Studies in the Development of a Xenograft-Derived Bone STUDIES IN THE DEVELOPMENT OF A XENOGRAFT-DERIVED BONE SCAFFOLD BY DANIEL NICHOLAS BRACEY A Dissertation Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE SCHOOL OF ARTS AND SCIENCES in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY Molecular Medicine and Translational Sciences May 2017 Winston-Salem, North Carolina Approved By Thomas L. Smith, Ph.D., Advisor Thomas C. Register, Ph.D., Chair Jeffrey S. Willey, Ph.D. L. Andrew Koman, M.D. Mark E. Van Dyke, Ph.D. DEDICATION I dedicate this dissertation to my family. To my wife, Mary, for her love and endless patience while I gave myself to this research, To my daughters, Lucy and Stirling, who have shown me joy, To my Mother, Jeri, for raising me to appreciate the value of education and hard work. ii ACKNOWLEDGEMENTS I would like to thank the Department of Orthopaedic Surgery for giving me the opportunity to pursue my training at Wake Forest. I thank Dr. Tom Smith, Dr. Beth Smith, Dr. Jason Lang and Dr. Andrew Koman for believing in my potential as an orthopaedic surgeon and extending me the physician scientist residency position. I thank my committee members for listening and thinking with me. I especially thank Dr. Jeff Willey for opening his lab and office to me at any hour of the day, and his generosity with time and resources. I thank Dr. Mark Van Dyke and Dr. Tom Register for challenging my understanding of scientific principles and broadening my knowledge. Thank you to my co-residents and fellow physician scientists for your support of my research interests. I am especially grateful to Dr. Patrick Whitlock and Dr. Thorsten Seyler for imparting their mentorship in my pursuit of this project. I thank Dr. Ian Hutchinson for his enthusiasm and teaching me cell culture principles. I thank Dr. Johannes Plate and Dr. Austin Stone for their mentorship ahead of me in the orthopaedic research lab. Lastly, I thank Dr. Robert Booth for inviting me into his operating room and opening my eyes to the field of orthopaedic surgery. His support, motivation and guidance have dramatically changed the course of my career. iii TABLE OF CONTENTS Dedication .......................................................................................................................... ii Acknowledgements ......................................................................................................... iii Table of Contents ............................................................................................................ iv List of Figures and Tables .............................................................................................. vi List of Abbreviations ..................................................................................................... vii Abstract ............................................................................................................................ ix CHAPTER 1 ...................................................................................................................... 1 An Introduction to Bone Biology and Bone Grafting Principles References ..................................................................................................................... 21 CHAPTER 2 .................................................................................................................... 26 The Development of a Xenograft-Derived Bone Scaffold: A Critical Evaluation of Scaffold Biology and Structure Abstract ........................................................................................................................ 27 Introduction .................................................................................................................. 29 Methods ........................................................................................................................ 31 Results ........................................................................................................................... 38 Discussion .................................................................................................................... 48 Conclusions .................................................................................................................. 52 References .................................................................................................................... 53 CHAPTER 3 .................................................................................................................... 61 Assessing the Biologic Safety of a Xenograft-Derived Bone Scaffold: In Vitro Cytocompatibility Studies and Quantification of the Alpha-Gal Epitope Abstract ........................................................................................................................ 62 Introduction .................................................................................................................. 64 Methods ........................................................................................................................ 66 Results ........................................................................................................................... 76 Discussion .................................................................................................................... 84 Conclusions .................................................................................................................. 89 References .................................................................................................................... 90 CHAPTER 4 .................................................................................................................... 96 Evaluation of the Osteoinductive Potential in a Xenograft-Derived Bone Scaffold Abstract ........................................................................................................................ 97 Introduction ................................................................................................................ 100 Methods ...................................................................................................................... 103 Results ......................................................................................................................... 110 Discussion .................................................................................................................. 124 iv Conclusions ................................................................................................................ 128 References .................................................................................................................. 130 CHAPTER 5 .................................................................................................................. 137 Summary of Dissertation ............................................................................................ 138 Future Directions ........................................................................................................ 140 References ................................................................................................................... 144 Appendix ........................................................................................................................ 147 Funding Sources.......................................................................................................... 147 Curriculum Vitae .......................................................................................................... 148 v LIST OF FIGURES AND TABLES Chapter 2 Figures and Tables Figure 1 Page 38 Figure 2 Page 39 Figure 3 Page 40 Figure 4 Page 43 Figure 5 Page 44 Table 1 Page 44 Table 2 Page 45 Table 3 Page 47 Chapter 3 Figures and Tables Figure 1 Page 71 Figure 2 Page 74 Figure 3 Page 76 Figure 4 Page 78 Figure 5 Page 78 Figure 6 Page 79 Figure 7 Page 81 Figure 8 Page 83 Figure 9 Page 84 Chapter 4 Figures and Tables Figure 1 Page 105 Figure 2 Page 112 Figure 3 Page 113 Figure 4 Page 115 Figure 5 Page 116 Figure 6 Page 119 Figure 7 Page 120 Figure 8 Page 121 Figure 9 Page 123 Chapter 5 Figures and Tables Figure 1 Page 142 vi LIST OF ABBREVIATIONS 2d Two-dimensional 3d Three-dimensional α-Gal Alpha-Gal Epitope (Galalpha1-3Galbeta1-(3)4GlcNAc-R) ACL Anterior Cruciate Ligament ALK Alkaline Phosphatase ANOVA Analysis of Variance ATCC American Type Culture Collection BMP Bone Morphogenic Protein BSA Bovine Serum Albumin CFU Colony Forming Unit Col1 Collagen-1 CT Computer tomography DAPI 4',6-diamidino-2-phenylindole DBM Demineralized Bone Matrix DICOM Digital Imaging and Communications in Medicine DMEM Dulbecco’s Modified Eagle’s Medium DNA Deoxyribonucleic Acid EDTA Ethylenediaminetetraacetic acid FBS Fetal Bovine Serum FEA Finite Element Analysis GF Gelfoam H&E Hematoxylin and Eosin vii HRP Horse Radish Peroxidase LPS Lipopolysaccharide MPa Megapascal M-PER Mammalian Protein Extraction Reagent MS Mass Spectrometry MSC Mesenchymal Stem Cell N Newton NHP Non-Human Primate OM Osteogenic Media PAA Peracetic Acid PCR Polymerase Chain Reaction RNA Ribonucleic Acid RUNX2 Runt-Related Transcription Factor 2 SAL Sterility Assurance Level SEM Scanning Electron Microscopy SV5 Simian Virus 5 TNFα Tumor Necrosis Factor Alpha viii ABSTRACT Bone grafts are used in nearly one half of all musculoskeletal surgeries and represent an enormous health care expenditure. Tissue-engineered bone graft substitutes have garnered considerable attention to
Recommended publications
  • Swiss Skydiver
    SUNDAY, AUGUST 16, 2020 DOMESTIC SPENDING UPSETS SPA DERBY SWISS SKYDIVER HOME Klaravich Stable=s Domestic Spending (GB) (Kingman {GB}), let SWEET IN THE ALABAMA go at 7-1, got the best of a host of challengers before just holding off the late-rushing Gufo (Declaration of War) to win the second Saratoga Derby Saturday at Saratoga. The win was the second on Saturday=s card for Klaravich and trainer Chad Brown, who unveiled another promising son of Kingman, the 2-year-old Public Sector, to win the day=s second race. AIn the paddock, I was confident that he would run a big race because he=s never acted better or more confident,@ said Brown, who won three races Saturday at Saratoga. AI was real proud of the horse.@ Heavily favored Decorated Invader (Declaration of War), Domestic Spending and No Word (Silent Name {Jpn}) all looked to be waiting for someone else to take the lead heading into the first turn and it was longshot Get Smokin (Get Stormy) who obliged, spurting up to take control of the early going. Cont. p6 Swiss Skydiver strolls home first in Alabama | Sarah Andrew A week after GI Kentucky Oaks contender Gamine (Into IN TDN EUROPE TODAY Mischief) romped home in the GI Test S., fellow sophomore filly standout Swiss Skydiver (Daredevil) produced a jaw-dropping MISHRIFF DOMINATES AT DEAUVILLE performance of her own with an effortless victory in the Prix du Jockey Club scorer Mishriff was the commanding winner of the G2 Prix Guillaume d’Ornano on Saturday. GI Alabama S.--a >Win and You=re In= race for the GI Longines Click or tap here to go straight to TDN Europe.
    [Show full text]
  • 3Rd Quarter 2001 Bulletin
    In This Issue... Promoting Colorectal Cancer Screening Important Information and Documentaion on Promoting the Prevention of Colorectal Cancer ....................................................................................................... 9 Intestinal and Multi-Visceral Transplantation Coverage Guidelines and Requirements for Approval of Transplantation Facilities12 Expanded Coverage of Positron Emission Tomography Scans New HCPCS Codes and Coverage Guidelines Effective July 1, 2001 ..................... 14 Skilled Nursing Facility Consolidated Billing Clarification on HCPCS Coding Update and Part B Fee Schedule Services .......... 22 Final Medical Review Policies 29540, 33282, 67221, 70450, 76090, 76092, 82947, 86353, 93922, C1300, C1305, J0207, and J9293 ......................................................................................... 31 Outpatient Prospective Payment System Bulletin Devices Eligible for Transitional Pass-Through Payments, New Categories and Crosswalk C-codes to Be Used in Coding Devices Eligible for Transitional Pass-Through Payments ............................................................................................ 68 Features From the Medical Director 3 he Medicare A Bulletin Administrative 4 Tshould be shared with all General Information 5 health care practitioners and managerial members of the General Coverage 12 provider/supplier staff. Hospital Services 17 Publications issued after End Stage Renal Disease 19 October 1, 1997, are available at no-cost from our provider Skilled Nursing Facility
    [Show full text]
  • Exploring Vigilance Notification for Organs
    NOTIFY - E xploring V igilanc E n otification for o rgans , t issu E s and c E lls NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation e 10,00 Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 Cover Bologna, piazza del Nettuno (photo © giulianax – Fotolia.com) © Testi Centro Nazionale Trapianti © 2011 EDITRICE COMPOSITORI Via Stalingrado 97/2 - 40128 Bologna Tel. 051/3540111 - Fax 051/327877 [email protected] www.editricecompositori.it ISBN 978-88-7794-758-1 Index Part A Bologna Consultation Report ............................................................................................................................................7 Part B Working Group Didactic Papers ......................................................................................................................................57 (i) The Transmission of Infections ..........................................................................................................................59 (ii) The Transmission of Malignancies ....................................................................................................................79 (iii) Adverse Outcomes Associated with Characteristics, Handling and Clinical Errors
    [Show full text]
  • Pferde Aus Deutschen Mutterlinien Liege in Der Aktu- Den Vergangenen Wochen Sind Für Die Jeweiligen Ver- Ellen Weltrangliste Der Galopper Ganz Weit Vorne
    Ausgabe 73 – Freitag, 31. Juli 2009 – 21 Seiten Aufgalopp Sea The Stars die Nummer eins Die Wettumsätze im deutschen Galopprennsport in Pferde aus deutschen Mutterlinien liege in der aktu- den vergangenen Wochen sind für die jeweiligen Ver- ellen Weltrangliste der Galopper ganz weit vorne. Nach anstalter aller Ehren wert. Hamburg, besonders Mün- dem von den internationalen Handicappern vorgelegten chen und Harzburg, aber auch andere Rennbahnen Liste ist Sea The Stars (Cape Cross) mit einem Rating konnten positive Zahlen vorlegen. Der Abwärtstrend von 131 die Nummer eins, gefolgt von Rip van Winkle scheint gestoppt zu sein. und Fame And Glory (Montjeu). Prix de Diane-Siege- Doch zu welchem Preis? Das Gros der Rennvereine rin Stacelita (Monsun) liegt auf Rang neun. hat sich gesundgeschrumpft, hat die Zahl der Rennta ge auf ein gerade noch erträgliches Maß zusammen- gestutzt. Nicht gesponserte Tage wurden gestrichen, Schiaparelli übrig geblieben ist im Vergleich zu früher ein Rumpf- programm. Die zwölf Renntage in Riem sind ein nicht gewinnt Goodwood Cup mehr ausreichendes Angebot für vor Ort ansässige Be- Nach einem starken Ritt von Frankie Dettori gewann sitzer, im Westen ist das Angebot genauso überschau- der auf 6:4 heruntergewettete Schiaparelli (Monsun) bar wie im Osten, Harzburg hat die Rennwoche ver- am Donnerstag im englischen Goodwood den Good- kleinert, alles geschah aus wirtschaftlichen Zwängen. wood Cup (Gr. II) über 2800 Meter. Platz zwei ging am Das wird sich auch so schnell nicht ändern. Rennta- Mourilyan (Desert Prince) vor The Betchwood Kid (To- ge, Rennwochen mögen wirtschaftlich durchzuführen bougg), dahinter belegte der zwölf Jahre alte Caracciola sein, doch Bahnpflege oder gar Baumaßnahmen sind (Lando) Rang vier.
    [Show full text]
  • Bone Grafting, Its Principle and Application: a Review
    OSTEOLOGY AND RHEUMATOLOGY Open Journal PUBLISHERS Review Bone Grafting, Its Principle and Application: A Review Haben Fesseha, MVSc, DVM1*; Yohannes Fesseha, MD2 1Department of Veterinary Surgery and Diagnostic Imaging, School of Veterinary Medicine, Wolaita Sodo University, P. O. Box 138, Wolaita Sodo, Ethiopia 2College of Health Science, School of Medicine, Mekelle University, P. O. Box1871, Mekelle, Ethiopia *Corresponding author Haben Fesseha, MVSc, DVM Assistant Professor, Department of Veterinary Surgery and Diagnostic Imaging, School of Veterinary Medicine, Wolaita Sodo University, P. O. Box: 138, Wolaita Sodo, Ethiopia;; E-mail: [email protected] Article information Received: March 3rd, 2020; Revised: March 20th, 2020; Accepted: April 11th, 2020; Published: April 22nd, 2020 Cite this article Fesseha H, Fesseha Y. Bone grafting, its principle and application: A review. Osteol Rheumatol Open J. 2020; 1(1): 43-50. doi: 10.17140/ORHOJ-1-113 ABSTRACT Bone grafting is a surgical procedure that replaces missing bone through transferring bone cells from a donor to the recipient site and the graft could be from a patient’s own body, an artificial, synthetic, or natural substitute. Bone grafts and bone graft substitutes are indicated for a variety of orthopedic abnormalities such as comminuted fractures (due to car accidents, falling from a height or gunshot injury), delayed unions, non-unions, arthrodesis, osteomyelitis and congenital diseases (rickets, abnormal bone development) and are used to provide structural support and enhance bone healing. Autogenous, allogeneic, and artificial bone grafts are common types and sources of grafts and the advancement of allografts, synthetic bone grafts, and new operative techniques may have influenced the use of bone grafts in recent years.
    [Show full text]
  • AMRITA HOSPITALS AMRITA AMRITA HOSPITALS HOSPITALS Kochi * Faridabad (Delhi NCR) Kochi * Faridabad (Delhi NCR)
    AMRITA HOSPITALS HOSPITALS AMRITA AMRITA AMRITA HOSPITALS HOSPITALS Kochi * Faridabad (Delhi NCR) Kochi * Faridabad (Delhi NCR) A Comprehensive A Comprehensive Overview Overview A Comprehensive Overview AMRITA INSTITUTE OF MEDICAL SCIENCES AIMS Ponekkara P.O. Kochi, Kerala, India 682 041 Phone: (91) 484-2801234 Fax: (91) 484-2802020 email: [email protected] website: www.amritahospitals.org Copyright@2018 AMRITA HOSPITALS Kochi * Faridabad (Delhi-NCR) A COMPREHENSIVE OVERVIEW A Comprehensive Overview Copyright © 2018 by Amrita Institute of Medical Sciences All rights reserved. No portion of this book, except for brief review, may be reproduced, stored in a retrieval system, or transmitted in any form or by any means —electronic, mechanical, photocopying, recording, or otherwise without permission of the publisher. Published by: Amrita Vishwa Vidyapeetham Amrita Institute of Medical Sciences AIMS Ponekkara P.O. Kochi, Kerala 682041 India Phone: (91) 484-2801234 Fax: (91) 484-2802020 email: [email protected] website: www.amritahospitals.org June 2018 2018 ISBN 1-879410-38-9 Amrita Institute of Medical Sciences and Research Center Kochi, Kerala INDIA AMRITA HOSPITALS KOCHI * FARIDABAD (DELHI-NCR) A COMPREHENSIVE OVERVIEW 2018 Amrita Institute of Medical Sciences and Research Center Kochi, Kerala INDIA CONTENTS Mission Statement ......................................... 04 Message From The Director ......................... 05 Our Founder and Inspiration Sri Mata Amritanandamayi Devi .................. 06 Awards and Accreditations .........................
    [Show full text]
  • Clinical Considerations in Facial Transplantation
    CLINICAL CONSIDERATIONS IN FACIAL TRANSPLANTATION by Anthony Renshaw A thesis submitted in fulfilment of the requirements of University College London for the degree of Doctor of Medicine January 2011 Department of Plastic and Reconstructive Surgery, Academic Division of Surgical & Interventional Sciences, University College London 1 Declaration I, Anthony Renshaw, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author. …………………………………………………………. 2 Abstract Facial transplantation has emerged as the next step on the reconstructive ladder for severe facial disfigurement. Clinical issues surrounding facial tissue donation are examined, comprising pre-transplant facial vessel delineation; pre-operative aesthetic matching; and attitudes towards donation. An anatomical study of 200 consecutive facial and transverse facial vessels was performed using colour Doppler ultrasound. Facial vessels were measured at three landmarks and their branching pattern documented. The facial artery main branch was detected at the lower mandibular border in 99.5% of cases, the accompanying facial vein in 97.5%. The transverse facial artery was present in 75.5% of cases, the vein found in 58%. When the facial artery was undetectable, there was transverse facial artery dominance. When the facial vein was absent it was replaced with a transverse facial vein. This provides valuable pre-operative information regarding vessel status. A quantitative eleven- point skin tonal matching scheme is described using digital analysis of facial imagery.
    [Show full text]
  • Equisoft Live Software Ideal for Studs, Trainers & Owners
    TUESDAY, 6TH NOVEMBER 2018 2018 KEENELAND BREEDINGNOVEMBER STOCK SALE THE Monday, November 5 to Friday, November 16 EBN WORLD’S EUROPEAN BLOODSTOCK NEWS STAGE FOR MORE INFORMATION: TEL: +44 (0) 1638 666512 • FAX: +44 (0) 1638 666516 • [email protected] • WWW.BLOODSTOCKNEWS.EU STAKES RESULTS | RACING ROUND-UP | POINTS OF VIEW | SIRES’ TABLE TODAY’S HEADLINES STALLION FEES 2019 CRACKSMAN TO STAND AT DALHAM HALL STUD Last year’s highest-rated European racehorse, Cracksman (Frankel), will stand at Dalham Hall Stud in Newmarket next year, commanding a fee of £25,000. The four-time Gr.1 winner was bred and raced by Anthony Oppenheimer and will stand alongside another graduate of Oppenheimer’s Hascombe and Valiant Studs nursery in Golden Horn, who is from the same female line and whose fee will again be £50,000. Another newcomer to the Dalham Hall roster is Hawkbill, Lady Aurelia (Scat Daddy) tops the Fasig-Tipton November whose two top-level triumphs came in the Gr.1 Eclipse Stakes and Sale at $7.5m on Sunday evening in Lexington. For full the Gr.1 Dubai Sheema Classic. The son of Kitten’s Joy, who was report, see page 7. © Fasig-Tipton placed in Gr.1 company five times, will stand for £7,500. Champion sprinter Harry Angel (Dark Angel), previously confirmed as standing at Dalham Hall Stud, will command a fee of £20,000 in his first season, while the dual Gr.1 winner Jungle Cat GOFFS AUTUMN SALE - PAGE 3 (Iffraaj), who has already been announced as standing at FASIG-TIPTON SALE - PAGE 7 Kildangan Stud next year, will stand for €8,000.
    [Show full text]
  • Consent for Bone Grafting
    Consent for Bone Grafting Grafting Procedure: __________________________________________________________________________ I understand that bone grafting and barrier membrane procedures include inherent risks such as, but not limited to the following: 1. Pain. Some discomfort is inherent in any oral surgery procedure. Grafting with materials that do not have to be harvested from your body is less painful because they do not require a donor site surgery, but pos-toperative pain is still likely. It can be largely controlled with pain medications and applying a cold compression to the surgical site. 2. Infection. No matter how carefully surgical sterility is maintained, it is possible, because of the existing non-sterile oral environment, for infections to occur post-operatively. At times these may be a serious nature. Should severe swelling occur, particularly accompanied with fever or malaise, professional attention should be received as soon as possible. 3. Bleeding, bruising, and swelling. Some moderate bleeding may last several hours. If profuse, you must contact us as soon as possible. Some swelling is normal, but if severe, you should notify us. Swelling usually starts to subside after about 48 hours. Bruises may persist for a week or so. 4. Loss of all or part of the graft. Success with bone and membrane grafting is high. Nevertheless, it is possible that the graft could fail. Despite meticulous surgery, particulate bone graft materials can migrate out of the surgery site and be lost. A membrane graft could start to dislodge. If so, the doctor should be notified. You compliance is essential to assure success. 5. Types of graft material.
    [Show full text]
  • 78581/2020/Estt-Ne Hr
    105 78581/2020/ESTT-NE_HR 1| T a r i f f - AIMS 106 78581/2020/ESTT-NE_HR INDEX 1. General Information ( Section A) 3 i. Out Patient Department ii. Ambulance Charges 2. General Information ( Section B) 5 i. Bed charges ii. In patient Consultation fees iii. Billing Of Surgery Anesthesia and OT Charges iv. Billing Of Surgery /Procedure/ others 3. LAB 9 4. Outsouce Lab 16 5. Blood Bank 64 6. Imaging & Radiodiagnosis 65 7. Non – Invasive Lab 80 8. Anesthesia 82 9. Cardiology and Cardiac Surgery 84 10. Critical Care Services 89 11. Baby Care 91 12. Common Procedure 94 13 Dental 94 14 Dermatology 101 15 E N T 105 16 Gastroenterology 110 17 Maxillo Facial Surgery 113 18 Nephrology 116 19 Neuro Diagnostic Lab 118 20 Oncology 112 21 Ophthalmology 136 22 Orthopedies 142 23 OBS & Gynaecology 149 24 Physiotherapy 154 25 Respiratory Medicine 156 26 Surgery & Major Procedures i. General Surgery 158 ii. Pediatric Surgery 165 iii. PlasticSurgery 170 iv. Neuro Surgery 182 27 Urology 185 28 Interventional Radiology 192 29 Interventional Pain Management 194 30 Paediatric Cardiac Surgery 197 31 Bed Side Service Charges200 2| T a r i f f - AIMS 107 78581/2020/ESTT-NE_HRSection – A GENERAL INFORMATION OUT PATIENT DEPARTMENT OPD Consultations: Superspeciality OPD Consultation * Rs. 700 Specialty OPD Consultation** Rs. 400 to 800 Note: OPD Timing Monday- Saturday ( 8:00AM – 7:00PM) *Super specialty Departments – Cardiac Surgery, Cardiology, Neurology, Neurosurgery, Oncology, Respiratory Medicine, Urology, Plastic Surgery, Gastroenterology, Endocrinology, Paediatric
    [Show full text]
  • Informed Consent for Bone Grafting Surgery
    INFORMED CONSENT FOR BONE GRAFTING SURGERY BONE GRAFTING The bone grafting procedure involves opening the gums in the area to expose the existing bone. This is then followed by placing bone material in such a manner so as to augment the existing bone horizontally or vertically. A protective barrier or membrane may then placed over the grafted bone for protection. The gums are then closed over and sutured (stitched) in place to completely cover the bone grafted area. A healing time of 4-6 months is then typically allowed for the bone graft to “take”, mature, and integrate with the surrounding native bone. As discussed, the bone graft material and membrane we’ll be using is derived from a donor source (animal or human) or synthetic. The materials I use have been documented to be safe and reliable. Expected Benefits The purpose of bone grafting in your case would be to increase the width of the existing bone to allow for proper implant placement. It may also help to harmonize the esthetics of the region. The amount of volume achieved is influenced by a number of factors. As such, some cases require multiple grafts to achieve the necessary volume in order to place an implant of a specific size. Principal Risks and Complications Although bone grafting of localized areas to increase the width of existing bone has been shown in clinical studies to be a predictable procedure, in some cases, patients do not respond successfully to the procedure and may require revision procedures to attain the desired result. Because each patient's condition is unique, the procedure may not be successful in preserving function or appearance for the long- term.
    [Show full text]
  • Journal of Vaccines, Immunology and Immunopathology Rijkers GT
    Journal of Vaccines, Immunology and Immunopathology Rijkers GT. J Vaccines Immunol 5: 148. Review Article DOI: 10.29011/2575-789X.000148 The Arrest of Christ: Autotransplantation from Miracle to Medical Procedure Ger T. Rijkers1,2* 1Department of Science, University College Roosevelt, Lange Noordstraat, CB Middelburg, The Netherlands 2Laboratory for Medical Microbiology and Immunology, St. Elisabeth Hospital, Tilburg, The Netherlands *Corresponding author: GT Rijkers, Department of Science, University College Roosevelt, Lange Noordstraat 1, CB Middelburg, The Netherlands Citation: Rijkers GT (2020) The Arrest of Christ: Autotransplantation from Miracle to Medical Procedure. J Vaccines Immunol 5: 148. DOI: 10.29011/2575-789X.000148 Received Date: 01 January, 2020; Accepted Date: 13 January, 2020; Published Date: 20 January, 2020 Abstract During the arrest of Christ, one of his disciples, Simon Peter, cut off the ear of a servant of Caiaphas. Christ put the ear back, a miracle and the first recorded autotransplantation. Currently, autotransplantation is an established procedure in reconstructive dental and bone surgery. Autotransplantation of splenic fragments can retain spleen function after splenectomy. Following pancreatectomy for chronic pancreatitis or benign or malignant diseases of the pancreas, islet autotransplantation can prevent diabetes. Autotransplantation of hematopoietic stem cells enables reconstitution of hematopoiesis after intense chemo and/or radiotherapy for leukemia and lymphoma. The development of biomedical technology to generate induced pluripotent stem cells, gene editing with CRISPR Cas, and in vitro organoid cultures opens the possibility to treat a wide array of inborn and acquired diseases by autotransplantation. Introduction The Temptation of St. Anthony (1500-1510) is an altarpiece by Jheronimus Bosch. Colorful altarpieces were closed during the Lenten period, the 40 days’ penitential preparation for Eastern, or just during the final week before Eastern, the Holy Week.
    [Show full text]